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Özet
Amaç:  Sunulan  çalışmanın  amacı,  hemodiyaliz  ve  sağlıklı  kişilerde  serum 
kadmiyum (Cd), total triiyodotironin (T3), total tiroksin (T4) ve adrenokor-
tikotropik hormon (ACTH) düzeyleri arasında istatistiksel olarak farklılık ve 
de gruplar arasında bu eser element ile tiroit profilleri ve ACTH arasında 
korelasyon olup olmadığını değerlendirmekti. Gereç ve Yöntem: Çalışmaya 
2-16 yıldır haftada en az üç kez diyalize giren, her seansı en az 4 saat olan 
47 hemodiyaliz hastası (hemodiyaliz grubu) ve 23 sağlıklı kişi (kontrol grubu) 
dahil edildi. Hemodiyaliz grubunda kan numuneleri diyaliz öncesi ve sonrası 
alındı. Kontrol grubunun kan numuneleri 10 saatlik açlık sonrası alındı. Bul-
gular: Total T3 (p≤0.001) düzeyleri kontrol grubunda diyaliz öncesi ve diyaliz 
sonrasına göre daha yüksekti. Total T3 (p≤0.05) düzeyleri diyaliz öncesi diya-
liz sonrasına göre daha düşüktü. Kontrol grubunda Total T4 düzeyleri yüksek, 
Cd düzeyleri ise düşük tespit edildi. Bu parametreler, diyaliz öncesine göre 
ise, istatistiksel açıdan önemli farklılık (sırasıyla p≤0.001, p≤0.01) gösterdi. 
ACTH düzeyleri bakımından gruplar arasında önemli bir farklılık bulunmadı.     
Tartışma: Hemodiyaliz hastalarında Cd düzeylerinin ölçülmesinin önemli ola-
bileceği kanısındayız. Ancak Cd, tiroit profilleri ve ACTH düzeyleri arasında 
önemli bir ilişki bulamadık.
Anahtar Kelimeler
ACTH; Total T3; Total T4; Kadmiyum; Hemodiyaliz
Abstract
Aim: The aim of the present study is to determine whether there are statisti-
cally differences between hemodialysis patients and control (healthy) groups 
according to level of serum cadmium (Cd), total triiodothyronine (T3) and 
total thyroxine (T4) and adrenocorticotropin hormone (ACTH), and besides 
whether there are any correlation coefficients of trace element with thyroid 
profiles, ACTH in these groups. Material and Methods:The study included 47 
hemodialysis patient who were dialyzed three times a week and each session 
was at least 4 hours. The duration of dialysis range were 2-16 yr. This gro-
up called as a “Hemodialyis group”. Blood samples were taken before (pre-
hemodialysis) and after (post-hemodialysis) hemodialysis session. “Control 
group” included 23 healthy volunteers with no medical problem. In control 
group, samples were taken after 10 hour fasting. Results: Levels of total 
T3 were higher in group of control than the levels of pre-hemodialysis and 
post-hemodialysis (p≤0.001). Total T3 levels were lower in pre-hemodialysis 
(p≤0.05) than those of post-hemodialysis. The highest level of total T4 and 
lowest level of Cd were in control group and these parameters were statisti-
cally different from the pre-hemodialysis (respectively p≤0.001, p≤0.01). We 
did not determine any significant differences between all groups according 
to data of ACTH levels. Discussion: We suggest that analyzing the levels of 
Cd may be useful for the hemodialysis patients. But, we did not determine a 
significant association between Cd and thyroid profiles and ACTH levels. 
Keywords
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Introduction
Chronic kidney disease is an important agent of morbidity and 
mortality all over the world. Dialysis in a patient with advanced 
chronic kidney disease is an important pace in medical science. 
During hemodialysis (HD), essential kidney functions such as 
the elimination of water and metabolic wastes as well as the 
correction of the electrolyte and acid/base state, are replaced 
by the artificial purification system. Elements such as Na+, K+, 
Ca++, Mg++, Cl–, and H+ must be kept in a rather narrow physi-
ological range; otherwise, life-threatening events may occur[1].
The effects of trace elements in blood and dialysis fluid of pa-
tients with chronic renal failure have been extensively investi-
gated. Several trace elements (including aluminum, cadmium, 
chromium, lanthanum, strontium and zinc) have been shown to 
accumulate in bone of uraemic patients[2-3]. On the basis of 
the results, the abnormal metabolism of trace metals contrib-
utes to a part of the uraemic symptoms, which is unresolved by 
maintenance hemodialysis[4]. Increased trace element concen-
trations can result from excessive homeopathic intake, adminis-
tration of parenteral fluids or blood contact with contaminated 
dialysate[3].
Cadmium (Cd) is a toxic metal with extremely long biological half 
time of 15-20 years in humans. Cd exposure can cause a variety 
of adverse health effects which are more prominent, e.g.kidney 
dysfunction, lung diseases, disturbed calcium metabolism[5-6].
 For the general population, the main sources of Cd exposure 
are diet (from contaminated water and crops grown on con-
taminated soil) and tobacco. Cadmium inhaled through ciga-
rette smoke is more easily adopted by the body than cadmium 
in food or water. About 40–60 percent of the cadmium inhaled 
in smoke is absorbed into the bloodstream, as against to the 
5–10 percent absorbed through foods. Chronic exposure to Cd 
often leads to renal dysfunction[1].  Exposure to occupational 
(previously or presently employed in Cd-battery production or 
residing in Cd-polluted areas near the battery plants) or rela-
tively low environmental (domicile 2-10 km from a plant) levels 
of Cd appears to be a determinant for the development of end-
stage renal disease[7].   The greatest accumulation occurs in 
the liver and kidneys[8].
Whereas some researchers[9] suggested significant alterations 
in  Cd  levels  in  hemodialysis  patients,  some  researchers[10] 
confirmed that hemodialysis patients, who were dialyzed with 
cuprophan dialyzer, did not show any significant alterations in 
serum Cd concentrations. 
Furthermore, patients with end stage renal disease display a 
variety of endocrine disturbances[11]. Mgbonyebi et al[12-13], 
conclude that the toxicity of Cd in adrenal functions causes hy-
peractivity in ACTH stimulation and expression. Besides, distur-
bances in thyroid function are common among patients on renal 
replacement therapy[14]. Chronic renal failure (CRF) affects thy-
roid function in multiple ways, including circulating thyroid hor-
mone concentration, altered peripheral hormone metabolism, 
disturbed binding to carrier proteins, possible reduction in thy-
roid hormone and increased iodine store in thyroid glands[15]. 
The most obvious abnormality observed in CRF patients is a 
reduction  in  the  serum  level  of  total  triiodothyronine  (T3). 
The serum levels of free T3 and total thyroxine (T4) are also 
reduced[16]. Moreover, it has been stated that if these patients 
developed hypothyroidism, free T4  values would fall and thy-
rotropin (TSH) values would rise simultaneously. Thus, free T4 
and TSH levels combined can be used for the diagnosis of hypo-
thyroidism in presence of CRF[11].
In this present study, we have purposed to determine the altera-
tions of Cd, thyroid profiles and ACTH levels between the he-
modialysis patients and healthy subjects, and besides whether 
there are any changes in these parameters between the groups 
of pre- and post-hemodialysis. Moreover, it has been aimed to 
find out whether there are any correlation coefficients of trace 
element with thyroid profiles, ACTH in these groups. 
Material and Method
Patients: Study was materialized with the 2001/130 numbered 
approvals  and  financial  support  of  the  Committee  of  Selcuk 
University of Scientific Research Projects Coordination Depart-
ment. Present study involved 47 hemodialysis patients (34 fe-
male, 13 male), who were treated in Polyclinic of Hemodialysis 
in Department of Nephrology of Medical Faculty of Selcuk Uni-
versity. The mean ages of the patients were 50,26±16,36 yr. All 
patients were dialyzed three times a week and each session was 
at least 4 hour. They were dialyzed with polysulfone dialyzing 
membrane. The duration of dialysis range were 2-16 yr. Those 
patients who had Hepatitis B, acute medical events, were us-
ing Al-containing drugs, were excluded in this study. This group 
called as “Hemodialysis Group”. 
“Control Group” was composed of 23 healthy volunteers (7 fe-
male, 16 male) with the mean age 39,52±11,54 yr. Those people 
had no any medical problem, were not using alcohol and were 
not smokers. 
Samples Collection: The blood samples were taken from the he-
modialysis patients in their regular monthly check-up. No extra 
blood samples were taken from the patients for those biochem-
ical parameters that were mentioned for this study. The blood 
samples  were  used  from  remains  of  their  check-up  sample. 
Samples were collected immediately before (pre-hemodialysis) 
and  after  the  dialysis  (post-hemodialysis)  sessions.  So  that, 
blood samples were not randomly collected. 
Samples of control group were taken after 10 hour fasting. Con-
trol group was selected from the people who were doing their 
ordinary check-up. For those biochemical parameters analyzing, 
the samples were used from remains of their check-up blood 
samples, extra blood samples were not taken. 
Blood samples were divided into two tubes (a tube with an an-
ticoagulant -EDTA and without an anticoagulant). The EDTA an-
ticoagulant samples were centrifuged at 2000 rpm for 10 min 
at +4°C. Plasma ACTH levels were analyzed immediately after 
taking blood samples. ACTH levels were determined in Immulite 
1000 OLYMPUS auto analyzer (BIODPC, Diagnostic Products 
Corporation 5700 West 96th Street Los Angeles, CA 90045-
5597,  USA)  by  using  Immulite  test  kit  (catalog  no:  LKAC1). 
Serum total T3 and total T4 concentrations were respectively 
determined by using Immulite test kits (catalog no: L2KT32, no: 
L2KT42) in Immulite 2000 OLYMPUS auto analyzer (BIODPC, 
Diagnostic Products Corporation 5700 West 96th Street Los 
Angeles, CA 90045-5597, USA). Serum samples were stored 
into polyethylene tubes at -85°C to analyze the levels of Cd. Cd 
levels were determined by inductively coupled plasma emission 
spectrometry (ICP-AES, Varian Australia Pty Ltd, Australia).
Statistical Analysis: Data were expressed as mean ± SE and an-
alyzed with SPSS packet program. ANOVA test was used among 
groups. Student’s t-test for parametric test (TT3, TT4, Cd) and 
Mann-Whitney U test for nonparametric tests (ACTH) were used 
to between the groups. Pearson Correlation coefficients were 
applied to evaluate the relationship between levels of trace ele-
ments and the other parameters. The levels of statistical signifi-
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cant were set at p≤0.05, p≤0.01, and p≤0.001. 
Results
As it has been shown in the table, there are no differences in Cd 
levels between the patients of after hemodialysis and before 
hemodialysis group. But, the lowest levels of Cd are in control 
group, and those are statistically different from those of pa-
tients group (p≤0.01).
However, we did not determine any significant differences be-
tween all groups according to data of ACTH levels. The highest 
levels of ACTH have been determined in control group.
Levels of total T3 were higher in group of control than the levels 
of pre- and post-hemodialysis (p≤0.001). Comparing patients 
group before hemodialysis and after hemodialysis sessions, we 
reported that total T3 levels were higher in post-hemodialysis 
(p≤0.05). Whereas there were no differences between the levels 
of total T4 in post-hemodialysis and control group, the lowest 
levels have been determined in pre-hemodialysis and were sta-
tistically different from those of control and post-hemodialysis 
(p≤0.001). 
Not only in post-hemodialysis but also in pre-hemodialysis group, 
a negative correlation between Cd and ACTH (respectively r= - 
0.273, r= - 0.261) and between Cd and total T4 (respectively 
r= - 0.243, r= - 0.096) were determined. But the correlations 
between the parameters were not statistically important (data 
were not shown in table).
Discussion
Nowadays, studies are different from each other in about al-
terations of levels of elements in hemodialysis patients. These 
differences can be attributed to variation of subjects’ criteria, 
which included to the study (number of subjects, duration of 
dialysis range), of times of blood samples collections and espe-
cially of dialysis membrane. According to this variations, finding 
different results are natural and are not enough to clarify the 
effects of elements in hemodialysis patients during their treat-
ments.
The concentration of several trace elements in end-stage renal 
failure patients is disturbed, and some of the trace metals un-
der study might share pathway of absorption, distribution and 
accumulation[2].
One of the studies[9], about the Cd metabolism in hemodialy-
sis patients, states that alterations in Cd levels are important 
in evaluation of the hemodialysis patients’ treatment. The re-
searchers studied on hemodialysis patients who were received 
maintenance hemodialysis for at least 3 months. The whole 
blood levels of Cd had been determined as 3.32±1,49 µg/l in 
patients and as 1.14±0.62 µg/l in healthy people (p<0.0001)[9]. 
In previous study[17] the researchers concluded that serum Cd 
concentrations were higher in group of hemodialysis than con-
trol group (p<0.001). Determining high levels of Cd in patients 
pre and post-dialysis in our study cause an agreement on notice 
of importance of Cd levels in hemodialysis patients with study 
of Lee et al[9] and Turan et al[17]. 
Our findings show that levels of  Cd in group of hemodialysis 
and control group are consistent with Kazi et al[1]’s data. The 
researchers showed that Cd concentrations were higher in group 
HD before hemodialysis (0.62±0.12 µ/l) and afer hemodialysis 
(0.40±0.15  µ/l)  than  control  group  (non-smokers  0.14±0.08, 
smokers 0.24±0.14 µ/l). 
However,  Malecka  et  al[10]  confirmed  that  hemodialysis  pa-
tients, who were dialyzed with cuprophan dialyzer, did not sig-
nificantly demonstrate any alterations in serum Cd concentra-
tion. So that, those results are not similar with our data. But in 
their other research Malecka et al[18] observed that during he-
modialysis session serum Cd levels increased significantly, when 
they compared two samples, which were taken during the dialy-
sis session in different times. We can say that the contradiction 
between the results may be attributed to differences of varia-
tion of dialysis membrane as Padovese et al.[19] mention that 
the type of dialytic treatment could play a role in determining 
the effective amounts of the elements, which are transferred 
from the dialysis fluid into the patient’s body. 
These decreased Cd levels may be related to nutritional intake, 
intestinal uptake and altered distribution and in addition, pro-
tein-bound trace elements may be lost more readily in the pres-
ence of proteinuria[3].
There are some studies[20,21], which have been focused on the 
levels of ACTH in hemodialysis patients. Letizia et al.[21], deter-
mined an unimportant differences between the levels of healthy 
group and of pre dialysis of ACTH and a significant high ACTH 
levels in post dialysis comparing with the levels of pre dialysis. 
Dolinska-Laskos et al.[20] noticed on the influence of long-term 
dialysis therapy on the pituitary-adrenal axis functions. They de-
termined that patients dialyzed longer than 100 months showed 
significantly high ACTH levels than controls. It has been found 
that CRF patients had significantly greater plasma ACTH levels 
than controls. Our results are not similar with those results[20-
21]. We did not determine significant differences between the 
groups according to criteria of our patients. Therefore, we con-
clude that there is no influence of dialysis therapy on the pitu-
itary-adrenal axis functions.
 The patients with CRF may be in a sub clinical hypothyroid 
state, although hemodilution has been seen to have a strong ef-
fect on the thyroid hormone concentrations[22].  Our data con-
cerning to total T3 levels are consistent but, total T4 levels in 
post-hemodialysis and control group are inconsistent with the 
result of Sakurai et al[22]. 
Xess et al.[23] presumed that patients showed significant de-
creases in T3 and T4 levels and serum levels of most hormones 
were altered because of several interplaying mechanisms.  Our 
data concerning to total T3 and total T4 are similar with Xess et 
al.[23]. Meanwhile, Lim[15] suggests that the low thyroid state 
in uremia serves to defend against protein wasting and that 
misguided attempts to repletion thyroid hormone stores may 
worsen protein malnutrition. 
As a result, data of Cd and ACTH and thyroid levels show that 
there are no relationships between each other. So that, when we 
focus on our data in the relation between ACTH and Cd, cannot 
cause an agreement on notice of relations of those parameters 
with the confirmation of Mgbonyebi et al.[12-13]. The research-
ers mentioned that Cd toxicity in adrenal functions caused hy-
peractivity in ACTH stimulation and expression[12-13].
In the face of the statistical significance of Cd, we can say that, 
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analyzing the levels of Cd may be important in monitoring hemo-
dialysis patients’ treatment. And also according to a study[24], 
Zinc (Zn) levels can be analyze with Cd levels because of the 
suggestion that iron deficiency increases the gastrointestinal 
absorption of Cd and Cd competes with zinc for binding sites on 
metallothionein which is important in the storage and transport 
of Zn during development. However, there are no associations 
between Cd and thyroid profiles, Cd and ACTH levels. Seen from 
this aspect, our study is not extensive to clarify the effects of 
trace elements in hemodialysis patients. The study is the first 
step to learn whether there are definite ratios of changes in 
the levels during the dialysis session. Therefore, our result may 
offer perspectives for future studies. Further extensive studies 
are necessary to clarify the effect of Cd levels alterations on 
hemodialysis patients’ prognosis, which can be performed on 
a different method (analysis dialysis fluid in addition to blood 
samples, more numbered patients and collecting samples in dif-
ferent times of dialysis session, etc.).
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